PlainRecalls
FDA Drug Moderate Class II Terminated

Linezolid Injection 600 mg/300 mL Rx Only, Manufactured in Hungary for TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454, NDC# 0703-9060-31- (Single Use Container), NDC# 0703-9060-33 (Box of 10 Singe Use Containers)

Reported: September 14, 2016 Initiated: June 17, 2016 #D-1495-2016

Product Description

Linezolid Injection 600 mg/300 mL Rx Only, Manufactured in Hungary for TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454, NDC# 0703-9060-31- (Single Use Container), NDC# 0703-9060-33 (Box of 10 Singe Use Containers)

Reason for Recall

CGMP Deviations

Details

Recalling Firm
Teva North America
Units Affected
92,480 containers
Distribution
Nationwide and Puerto Rico
Location
Horsham, PA

Frequently Asked Questions

What product was recalled?
Linezolid Injection 600 mg/300 mL Rx Only, Manufactured in Hungary for TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454, NDC# 0703-9060-31- (Single Use Container), NDC# 0703-9060-33 (Box of 10 Singe Use Containers). Recalled by Teva North America. Units affected: 92,480 containers.
Why was this product recalled?
CGMP Deviations
Which agency issued this recall?
This recall was issued by the FDA Drug on September 14, 2016. Severity: Moderate. Recall number: D-1495-2016.